心血管-肾脏-代谢综合征最早期阶段炎症指标hs-CRP已升高
Inflammation is already elevated at the earliest stage of cardiovascular-kidney-metabolic syndrome
一项基于4,315名美国成年人的分析显示,在心血管-肾脏-代谢(CKM)综合征从0期到1期的过程中,炎症标志物高敏C反应蛋白(hs-CRP)平均浓度几乎翻倍并超过2 mg/L,这是各阶段中增幅最大的变化。
A new analysis of U.S. national health data finds that high-sensitivity C-reactive protein (hs-CRP), a blood marker of inflammation, rises across the stages of cardiovascular-kidney-metabolic (CKM) syndrome, with the largest increase at the earliest stage.
The study, a collaboration between researchers at the University of Eastern Finland and Rutgers Robert Wood Johnson Medical School, was published open access in the European Journal of Preventive Cardiology and presented at the European Society of Cardiology Congress 2026.
The American Heart Association introduced CKM syndrome in 2023 to describe how heart disease, kidney disease, obesity and type 2 diabetes are linked. It runs from stage 0 (no risk factors) and stage 1 (excess or unhealthy body fat) through stage 2 (conditions such as high blood pressure, diabetes or kidney disease) to stages 3 and 4 (early and established heart disease).
The team analyzed data from 4,315 adults in the 2015–2018 National Health and Nutrition Examination Survey (NHANES). Participants' average age was 48 years, and half were women. Average hs-CRP nearly doubled between stage 0 and stage 1, the largest change seen across all stages, and crossed 2 mg/L, the level commonly used to signal increased cardiovascular risk. From stage 1 onward, average levels stayed above this threshold, rising only modestly at stage 2 before leveling off.
The findings suggest that inflammation is already present at the first stage of CKM syndrome. The authors note that hs-CRP is best understood as an easy-to-measure warning sign of underlying inflammation rather than a treatment target in itself. Because the study looked at a single point in time, it shows an association but cannot prove that inflammation drives the syndrome forward. Studies that follow people over time and trials testing early prevention are now needed.
"What stood out to us is that inflammation was already elevated at the very first stage, before people had developed diabetes, kidney disease or heart disease, which is where we may have the most room to change the course," said lead author Douglas R. Corsi, M.D., a physician at Rutgers Robert Wood Johnson Medical School and a Ph.D. student at the University of Eastern Finland.
"This makes a strong case for early prevention, either by treating inflammation directly or by reducing excess body fat through lifestyle and dietary changes while using an inexpensive blood test like hs-CRP to track the risk," said Andrew Agbaje, M.D., M.P.H., Ph.D., the study's senior author, associate professor (Docent) of clinical epidemiology and child health at the University of Eastern Finland.
Publication details
Douglas R Corsi et al., High-sensitivity C-reactive protein across the cardiovascular–kidney–metabolic syndrome spectrum: a nationally representative, survey-weighted analysis of US adults, European Journal of Preventive Cardiology (2026). DOI: 10.1093/eurjpc/zwag476
Journal information: European Journal of Preventive Cardiology
Key medical concepts
Who's behind this story?
Swati Mestri
Swati Mestri holds a bachelor's degree in Electronics Engineering and has worked as a content editor since 2019. She has experience editing research documents across technology, health care, and materials science, and has a particular interest in technology and space. Full profile →
Andrew Zinin
Master's in physics with research experience. Long-time science news enthusiast. Plays key role in Science X's editorial success. Full profile →
Citation: Inflammation is already elevated at the earliest stage of cardiovascular-kidney-metabolic syndrome (2026, October 14) retrieved 14 October 2026 from https://medicalxpress.com/news/2026-10-inflammation-elevated-earliest-stage-cardiovascular.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
来源:Medical Xpress · medicalxpress.com